Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD.
Fanka Gilevska, MD, PhD
Advertisement
Articles by Fanka Gilevska, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
ONL Therapeutics randomizes first European patient in phase 2 GA trial of Xelafaslatide
2
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
3
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
4
Ophthalmic drug shortages more frequent, longer lasting than average
5